statistiche ricercatore

Nome	#
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies	138
Biweekly hizentra® in primary immunodeficiency: A multicenter, observational cohort study (IBIS)	124
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)	84
Stray light calibration for the Solar Orbiter/Metis solar coronagraph	80
Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study	70
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram	61
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity	54
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies	52
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)	50
Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature	40
Totale	753

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	158	2	14	4	11	23	16	14	20	15	16	20	3
2020/2021	163	16	16	0	24	8	12	14	11	20	19	10	13
2021/2022	95	15	1	4	3	6	14	3	4	6	5	13	21
2022/2023	239	15	60	12	4	11	30	27	16	32	4	10	18
2023/2024	83	1	7	10	6	8	9	5	22	2	8	2	3
2024/2025	15	15	0	0	0	0	0	0	0	0	0	0	0
Totale													753